在细胞应激条件下,RSK1的非法定激活诱导EphA2-介导的细胞迁移
Yue Zhou1, Fang Zhang1, Akihiro Tanaka1
1Department of Cancer Cell Biology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Toyama 930-0194, Japan.
Biological & pharmaceutical bulletin
|July 28, 2025
概括
一个新的途径激活p90核糖体S6激酶1 (RSK1) 通过3-氨基酸依赖激酶1 (PDK1) 和基因激活蛋白激酶激活蛋白激酶2 (MK2). 这种PDK1-MK2-RSK1-EphA2轴驱动质母细胞细胞迁移,为癌症恶性提供了新的见解.
科学领域:
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
- 癌症研究 癌症研究
背景情况:
- p90核糖体S6激酶1 (RSK1) 对于细胞生长和迁移至关重要.
- 在Ser-897中对以弗林受体A2 (EphA2) 的RSK1酸化促进了癌细胞迁移.
- RSK1的激活由细胞外信号调节激酶 (ERK) 和基激活蛋白激酶激活蛋白激酶2 (MK2) 调节,MK2通路的理解较少.
研究的目的:
- 阐明由MK2激活RSK1的机制.
- 研究PDK1-MK2-RSK1-EphA2信号轴在质母细胞瘤中的作用.
- 了解这种途径对泰莫索洛米德诱导的细胞迁移的贡献.
主要方法:
- 研究的RSK1化位点,特别是Ser-380和Ser-221.
- 使用生物化学分析来确定酶依赖性 (PDK1,MK2,ERK).
- 检查了对质母细胞瘤细胞迁移的功能影响,以应对temozolomide.
主要成果:
- 在Ser-380中通过MK2-介导的RSK1酸化需要在Ser-221中进行基底酸化.
- -221基底酸化是由3-酸依赖性激酶1 (PDK1) 催化,并且独立于ERK.
- 该PDK1-MK2-RSK1-EphA2通路显著促进由temozolomide诱导的质母细胞细胞迁移.
结论:
- 透露了一种新的,PDK1-依赖的RSK1通过MK2激活机制.
- 确定了一个新的信号轴 (PDK1-MK2-RSK1-EphA2),对于质母细胞细胞迁移至关重要.
- 这一途径代表了增强质母细胞瘤化疗疗效能的潜在治疗标.
相关概念视频
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
Cell Polarization by Rho Proteins
2.8K
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.8K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K


